Evidence map›Paper›PMID 34626287›Full record

ArticleInternational journal of clinical oncology2022

Clinical impact of primary tumour

Elwira Szychot, Daniel Morgenstern, Mark Chopra, Stefania Sorrentino, Owen Arthurs, Neil Sebire, Farrukh Arfeen, Andrzej Brodkiewicz, Paul Humphries, Lorenzo Biassoni

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

Elwira SzychotClinical Studies, The Institute of Cancer Research, Sutton, UK. e.szychot@nhs.net.ORCID http://orcid.org/0000-0002-1598-7018
Daniel MorgensternDepartments of Haematology/Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Mark ChopraDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Stefania SorrentinoDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Owen ArthursDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Neil SebireDepartment of Pathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Farrukh ArfeenDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Andrzej BrodkiewiczDepartment of Paediatrics, Child's Nephrology, Dialysis Therapy and Acute Poisoning, Szczecin, Poland.
Paul HumphriesDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Lorenzo BiassoniDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust · GBMaritime University of Szczecin · PLRoyal Marsden NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMore than 50% children with high-risk neuroblastoma (HR-NBL) experience disease progression, which we hypothesise is due to non-response of primary tumour to treatment. Current imaging techniques are unable to characterise response in primary tumour (necrotic versus viable tissue) at diagnosis or follow-up.

objectivesCompare clinico-histological characteristics between primary

methodsRetrospective review of clinico-radiological data of children diagnosed with

resultsSixteen of 61 patients showed complete primary tumour

conclusions

Indexed as

Induction ChemotherapyNeuroblastomaAntineoplastic Combined Chemotherapy ProtocolsHumansInfantRetrospective Studies123ImIBGChildrenHigh-risk neuroblastomaPrimary tumour

Identifiers

PMID34626287
OpenAlexW3204844508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.